• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉腿部压迫用于改善充血性心力衰竭患者的组织充血情况。

Venous Leg Compression for Tissue Decongestion in Patients With Worsening Congestive Heart Failure.

作者信息

Civera Jose, Miñana Gema, de la Espriella Rafael, Santas Enrique, Sastre Clara, Mollar Anna, Conesa Adriana, Martínez Ana, Núñez Eduardo, Bayés-Genís Antoni, Núñez Julio

机构信息

Cardiology Department, Hospital Clínico Universitario de Valencia, INCLIVA Instituto de Investigación Sanitaria, Valencia, Spain.

Department of Medicine, Universitat de València, Valencia, Spain.

出版信息

Front Cardiovasc Med. 2022 Jul 8;9:847450. doi: 10.3389/fcvm.2022.847450. eCollection 2022.

DOI:10.3389/fcvm.2022.847450
PMID:35872894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9304621/
Abstract

AIMS

Venous leg compression (VLC) with elastic bandages has been proposed as a potentially useful strategy for decreasing tissue congestion. We aimed to evaluate the effect of VLC on short-term changes on intravascular refill, assessed by inferior vena cava (IVC) diameter in patients with worsening heart failure (WHF) requiring parenteral furosemide. Additionally, we sought to evaluate whether early changes in IVC were related to short-term decongestion.

METHODS

This is a prospective study in which we included 20 consecutive ambulatory patients with WHF treated with subcutaneous furosemide and VLC for at least 72 h. The endpoints were (a) short-term changes in IVC, (b) the association between decongestion and 3-h IVC changes following VLC. Changes in continuous endpoints and their longitudinal trajectories were estimated with linear mixed regression models. All analyses were adjusted for multiple comparisons.

RESULTS

Following administration of subcutaneous furosemide and VLC, we found a significant increase in 3-h IVC diameter (ΔIVC = 1.6 mm, CI 95%: 0.7-2.5; < 0.001), with a greater increase in those with baseline IVC≤21 mm (2.4 vs. 0.8 mm; < 0.001). 3-h intravascular refill (increase in IVC≥2 mm) was associated with greater decongestion (natriuresis, weight, peripheral edemas, and dyspnea) in those with baseline IVC≤21 mm but not when IVC>21 mm ( < 0.05 for all comparisons).

CONCLUSIONS

In this cohort of patients with congestive WHF treated with subcutaneous furosemide and VLC, we found a greater increase in short-term IVC in those with IVC ≤21 mm at baseline. In this subset of patients, a 3-h increase in IVC≥2 mm was associated with greater short-term decongestion.

摘要

目的

已有人提出使用弹性绷带进行腿部静脉压迫(VLC)作为减轻组织充血的一种潜在有效策略。我们旨在评估VLC对需要肠外使用呋塞米的失代偿性心力衰竭(WHF)患者血管再充盈短期变化的影响,通过下腔静脉(IVC)直径进行评估。此外,我们试图评估IVC的早期变化是否与短期去充血有关。

方法

这是一项前瞻性研究,我们纳入了20例连续的门诊WHF患者,这些患者接受皮下呋塞米和VLC治疗至少72小时。终点指标为:(a)IVC的短期变化;(b)VLC后3小时IVC变化与去充血之间的关联。使用线性混合回归模型估计连续终点指标的变化及其纵向轨迹。所有分析均针对多重比较进行了校正。

结果

在给予皮下呋塞米和VLC后,我们发现3小时时IVC直径显著增加(ΔIVC = 1.6 mm,95%置信区间:0.7 - 2.5;P < 0.001),基线IVC≤21 mm的患者增加幅度更大(2.4 vs. 0.8 mm;P < 0.001)。基线IVC≤21 mm的患者中,3小时血管再充盈(IVC增加≥2 mm)与更大程度的去充血(利钠、体重、外周水肿和呼吸困难)相关,但IVC>21 mm时则不然(所有比较P < 0.05)。

结论

在这组接受皮下呋塞米和VLC治疗的充血性WHF患者中,我们发现基线IVC≤21 mm的患者短期IVC增加幅度更大。在这一患者亚组中,IVC在3小时内增加≥2 mm与更大程度的短期去充血相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/dea3934e41e5/fcvm-09-847450-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/ec5f6ee0df01/fcvm-09-847450-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/9d25b41ace6c/fcvm-09-847450-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/d277ac75553e/fcvm-09-847450-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/690937d4d682/fcvm-09-847450-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/4245fd63c1e0/fcvm-09-847450-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/dea3934e41e5/fcvm-09-847450-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/ec5f6ee0df01/fcvm-09-847450-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/9d25b41ace6c/fcvm-09-847450-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/d277ac75553e/fcvm-09-847450-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/690937d4d682/fcvm-09-847450-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/4245fd63c1e0/fcvm-09-847450-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8da6/9304621/dea3934e41e5/fcvm-09-847450-g0006.jpg

相似文献

1
Venous Leg Compression for Tissue Decongestion in Patients With Worsening Congestive Heart Failure.静脉腿部压迫用于改善充血性心力衰竭患者的组织充血情况。
Front Cardiovasc Med. 2022 Jul 8;9:847450. doi: 10.3389/fcvm.2022.847450. eCollection 2022.
2
Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study.非制剂型呋塞米皮下输注治疗心力衰竭恶化患者的疗效和安全性:一项真实世界研究。
J Cardiovasc Transl Res. 2022 Jun;15(3):644-652. doi: 10.1007/s12265-021-10173-1. Epub 2021 Oct 12.
3
Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: The Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF vs HFrEF- DRY-OFF study.评估射血分数保留和降低的心衰急性失代偿患者的充血表型:HFpEF 与 HFrEF- DRY-OFF 研究中急性失代偿心衰治疗期间的去充血研究。
Eur J Intern Med. 2022 Mar;97:69-77. doi: 10.1016/j.ejim.2021.11.010. Epub 2021 Nov 26.
4
Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA-ADHF-DZHK10 trial.下腔静脉超声在急性失代偿性心力衰竭中的应用:CAVA-ADHF-DZHK10 试验的设计原理。
ESC Heart Fail. 2020 Jun;7(3):973-983. doi: 10.1002/ehf2.12598. Epub 2020 Jan 28.
5
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.急性心力衰竭中的充血消除策略与肾素-血管紧张素-醛固酮系统激活
JACC Heart Fail. 2015 Feb;3(2):97-107. doi: 10.1016/j.jchf.2014.09.003. Epub 2014 Oct 31.
6
Inferior vena cava diameter change after intravenous furosemide in patients diagnosed with acute decompensated heart failure.急性失代偿性心力衰竭患者静脉注射呋塞米后下腔静脉直径的变化
J Clin Ultrasound. 2015 Mar;43(3):187-93. doi: 10.1002/jcu.22173. Epub 2014 Jun 4.
7
Prospective evaluation of intravascular volume status in critically ill patients: does inferior vena cava collapsibility correlate with central venous pressure?危重症患者血管内容量状态的前瞻性评估:下腔静脉塌陷率与中心静脉压相关吗?
J Trauma Acute Care Surg. 2014 Apr;76(4):956-63; discussion 963-4. doi: 10.1097/TA.0000000000000152.
8
Longitudinal BNP follow-up as a marker of treatment response in acute heart failure: Relationship with objective markers of decongestion.急性心力衰竭治疗反应标志物:利钠肽纵向随访与充血消除客观标志物的关系
Int J Cardiol. 2016 Oct 15;221:167-70. doi: 10.1016/j.ijcard.2016.06.174. Epub 2016 Jun 27.
9
[Prognostic value of measuring the diameter and inspiratory collapse of the inferior vena cava in acute heart failure].[测量下腔静脉直径及吸气塌陷在急性心力衰竭中的预后价值]
Rev Clin Esp (Barc). 2016 May;216(4):183-90. doi: 10.1016/j.rce.2015.11.012. Epub 2016 Jan 13.
10
Echocardiographic markers of severe tricuspid regurgitation associated with right-sided congestive heart failure.与右侧充血性心力衰竭相关的严重三尖瓣反流的超声心动图标志物。
J Heart Valve Dis. 2003 Mar;12(2):197-201.

引用本文的文献

1
Therapeutic role of venous leg compression in worsening heart failure with predominant extravascular congestion: a case report.腿部静脉压迫在以血管外充血为主的心力衰竭恶化中的治疗作用:一例报告
Eur Heart J Case Rep. 2025 Jul 23;9(8):ytaf343. doi: 10.1093/ehjcr/ytaf343. eCollection 2025 Aug.
2
Home intravenous diuretic administration for heart failure management: A scoping review.用于心力衰竭管理的家庭静脉利尿剂给药:一项范围综述。
PLoS One. 2025 Jan 17;20(1):e0316851. doi: 10.1371/journal.pone.0316851. eCollection 2025.
3
Case report: Alternative approach for management of refractory volume overload in heart failure: usefulness of venous leg compression.

本文引用的文献

1
Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis.呋塞米联合白蛋白与单纯呋塞米治疗的利尿效果比较:一项更新的系统评价和荟萃分析。
PLoS One. 2021 Dec 1;16(12):e0260312. doi: 10.1371/journal.pone.0260312. eCollection 2021.
2
Effects of empagliflozin on CA125 trajectory in patients with chronic congestive heart failure.恩格列净对慢性充血性心力衰竭患者 CA125 轨迹的影响。
Int J Cardiol. 2021 Sep 15;339:102-105. doi: 10.1016/j.ijcard.2021.06.045. Epub 2021 Jun 30.
3
The struggle towards a Universal Definition of Heart Failure-how to proceed?
病例报告:心力衰竭难治性容量超负荷管理的替代方法:下肢静脉压迫的效用
Front Cardiovasc Med. 2023 Sep 29;10:1230980. doi: 10.3389/fcvm.2023.1230980. eCollection 2023.
迈向心力衰竭通用定义的努力——如何推进?
Eur Heart J. 2021 Jun 21;42(24):2331-2343. doi: 10.1093/eurheartj/ehab082.
4
Compression therapy for leg oedema in patients with heart failure.心力衰竭患者腿部水肿的压迫疗法。
ESC Heart Fail. 2020 Oct;7(5):2012-2020. doi: 10.1002/ehf2.12848. Epub 2020 Jul 25.
5
Elastic Bandage vs Hypertonic Albumin for Diuretic-Resistant Volume-Overloaded Patients in Intensive Care Unit: A Propensity-Match Study.弹性绷带与高渗白蛋白在 ICU 利尿剂抵抗性容量超负荷患者中的应用:一项倾向评分匹配研究。
Mayo Clin Proc. 2020 Aug;95(8):1660-1670. doi: 10.1016/j.mayocp.2020.03.029. Epub 2020 Jun 27.
6
Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment.心力衰竭中的充血:对生理学、诊断和治疗的当代观察。
Nat Rev Cardiol. 2020 Oct;17(10):641-655. doi: 10.1038/s41569-020-0379-7. Epub 2020 May 15.
7
Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review.心力衰竭患者的利尿剂治疗:JACC 最新综述。
J Am Coll Cardiol. 2020 Mar 17;75(10):1178-1195. doi: 10.1016/j.jacc.2019.12.059.
8
Safety of compression therapy for venous ulcer disease in the setting of congestive heart failure.充血性心力衰竭患者静脉溃疡疾病的压迫疗法的安全性。
Phlebology. 2020 Sep;35(8):556-560. doi: 10.1177/0268355520905178. Epub 2020 Feb 6.
9
Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes.基于急诊科就诊时灌注和淤血体征和症状的急性心力衰竭的临床表型及其与患者管理和结局的关系。
Eur J Heart Fail. 2019 Nov;21(11):1353-1365. doi: 10.1002/ejhf.1502. Epub 2019 Jun 18.
10
The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology.心力衰竭伴充血时利尿剂的应用——欧洲心脏病学会心力衰竭协会立场声明。
Eur J Heart Fail. 2019 Feb;21(2):137-155. doi: 10.1002/ejhf.1369. Epub 2019 Jan 1.